GBDC Stock +24.76% Since The Golden Star Was Identified GBDC Stock +24.76% Since The Golden Star Was Identified Unlock Golden Star List
RSI low/high Values: [ 20 - 80 ]
* StockInvest.us uses dynamically calculated RSI max/min levels to determine when stock is oversold or overbought based on historical behavior.

FAQ

What is the symbol for 9 Meters Biopharma, Inc. Stock and on which exchange is it traded?
The symbol for 9 Meters Biopharma, Inc. is NMTR and it is traded on the NASDAQ (NASDAQ Stock Exchange).

Should I buy or sell 9 Meters Biopharma, Inc. Stock?
9 Meters Biopharma, Inc. holds several positive signals, but we still don't find these to be enough for a buy candidate. At the current level, it should be considered as a hold candidate (hold or accumulate) in this position whilst awaiting further development.

How to buy 9 Meters Biopharma, Inc. Stock?
9 Meters Biopharma, Inc. Stock can be purchased through just about any brokerage firm, including online brokerage services.
Click here for our free guide on how to buy 9 Meters Biopharma, Inc. Stock.

What's the current price of 9 Meters Biopharma, Inc. Stock?
As of the end of day on the 2023-11-20, the price of an 9 Meters Biopharma, Inc. (NMTR) share was $0.0722.

What is the 52-week high and low for 9 Meters Biopharma, Inc. Stock?
The 52-week high for 9 Meters Biopharma, Inc. Stock is $2.79 and the 52-week low is $0.0150.

What is the market capitalization of 9 Meters Biopharma, Inc. Stock?
As of the 2023-11-20, the market capitalization of 9 Meters Biopharma, Inc. is 1.044M.
Click to get the best stock tips daily for free!

About 9 Meters Biopharma, Inc.

9 Meters Biopharma. 9 Meters Biopharma, Inc., a clinical-stage biopharmaceutical company, focuses on treatments for people with rare digestive diseases, gastrointestinal conditions with unmet needs, and debilitating disorders. The company is developing Larazotide, an 8-amino acid peptide, which is in Phase 3 clinical trial for the treatment of celiac disease, as well as in Phase IIa clinical trial for treatment of multi-system inflammatory syndrome; and Vurolenatide... NMTR Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT